Produção Nacional
The Brazilian Society of Rheumatology guidelines for axial spondyloarthritis – 2019
2020; BioMed Central; Volume: 60; Issue: 1 Linguagem: Inglês
10.1186/s42358-020-0116-2
ISSN2523-3106
AutoresGustavo Gomes Resende, Eduardo de Souza Meirelles, Cláudia Diniz Lopes Marques, Adriano Chiereghin, André Marun Lyrio, Antônio Carlos Ximenes, Carla Gonçalves Schahin Saad, Célio Roberto Gonçalves, Charles Lubianca Kohem, Cláudia Goldenstein‐Schainberg, Cristiano Campanholo, Júlio Sílvio de Sousa Bueno Filho, Lenise Brandao Pieruccetti, Mauro Waldemar Keiserman, Michel Alexandre Yazbek, Penélope Esther Palominos, Rafaela Silva Guimarães Gonçalves, Ricardo da Cruz Lage, Rodrigo Luppino Assad, Rubens Bonfiglioli, Sônia Maria Alvarenga Anti, Sueli Carneiro, Thauana Luiza de Oliveira, Valdeŕilio Feijó Azevedo, Washington A. Bianchi, Wanderley Marques Bernardo, Marcelo Antônio Amaro Pinheiro, Percival D. Sampaio‐Barros,
Tópico(s)Autoimmune and Inflammatory Disorders Research
ResumoAbstract Spondyloarthritis is a group of chronic inflammatory systemic diseases characterized by axial and/or peripheral joints inflammation, as well as extra-articular manifestations. The classification axial spondyloarthritis is adopted when the spine and/or the sacroiliac joints are predominantly involved. This version of recommendations replaces the previous guidelines published in May 2013. A systematic literature review was performed, and two hundred thirty-seven studies were selected and used to formulate 29 recommendations answering 15 clinical questions, which were divided into four sections: diagnosis, non-pharmacological therapy, conventional drug therapy and biological therapy. For each recommendation the level of evidence supporting (highest available), the strength grade according to Oxford, and the degree of expert agreement (inter-rater reliability) is informed. These guidelines bring evidence-based information on clinical management of axial SpA patients, including, diagnosis, treatment, and prognosis.
Referência(s)